Literature DB >> 2010550

Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution.

F S di Giovine1, S E Malawista, E Thornton, G W Duff.   

Abstract

Crystals of monosodium urate (MSU) provide a dose-dependent stimulus for the production by human blood monocytes of tumor necrosis factor (TNF), a cytokine with proinflammatory properties; TNF activity was inhibited selectively by monoclonal antibody to TNF alpha. Biologically active cell-associated TNF activity peaked at 3 h and was exceeded at 6 h by extracellular activity, which peaked at 12-18 h. Comparable kinetics were observed with immunoreactive TNF alpha. TNF alpha mRNA accumulation in monocytes stimulated with MSU crystals appeared as a single peak at 2-4 h, kinetics compatible with rapid production of a short half-life transcript. In contrast, crystals of calcium pyrophosphate or of hydroxyapatite did not stimulate significant production of TNF or of message. Fresh tophaceous material from a patient with gout contained significant levels of TNF alpha and cells cultured from the tophus produced TNF alpha in vitro. In rheumatoid synovial cells, spontaneous release of TNF alpha was increased by in vitro exposure to MSU crystals. Taken together with earlier work, these results support an expanded view of gouty inflammation in which the crystal-stimulated production of cytokines provides a crucial link between crystal deposition and many of the clinical and pathological facts of both acute and chronic gouty arthritis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2010550      PMCID: PMC295177          DOI: 10.1172/JCI115142

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  Expression of cell-cycle-dependent genes in phytohemagglutinin-stimulated human lymphocytes.

Authors:  L Kaczmarek; B Calabretta; R Baserga
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

2.  Comparison of in vitro cell cytotoxic assays for tumor necrosis factor.

Authors:  D A Flick; G E Gifford
Journal:  J Immunol Methods       Date:  1984-03-30       Impact factor: 2.303

3.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

4.  Co-existence of vinculin and a vinculin-like protein of higher molecular weight in smooth muscle.

Authors:  J R Feramisco; J E Smart; K Burridge; D M Helfman; G P Thomas
Journal:  J Biol Chem       Date:  1982-09-25       Impact factor: 5.157

5.  The detection of endotoxin by in vitro production of endogenous pyrogen: comparison with limulus amebocyte lysate gelation.

Authors:  G W Duff; E Atkins
Journal:  J Immunol Methods       Date:  1982-08-13       Impact factor: 2.303

6.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.

Authors:  D Pennica; G E Nedwin; J S Hayflick; P H Seeburg; R Derynck; M A Palladino; W J Kohr; B B Aggarwal; D V Goeddel
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

7.  The fever of gout: urate crystals activate endogenous pyrogen production from human and rabbit mononuclear phagocytes.

Authors:  G W Duff; E Atkins; S E Malawista
Journal:  Trans Assoc Am Physicians       Date:  1983

Review 8.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

9.  Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages.

Authors:  T Decker; M L Lohmann-Matthes; G E Gifford
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

10.  Failure of rabbit neutrophils to secrete endogenous pyrogen when stimulated with staphylococci.

Authors:  D F Hanson; P A Murphy; B E Windle
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

View more
  64 in total

1.  Role of the leucine-rich repeat domain of cryopyrin/NALP3 in monosodium urate crystal-induced inflammation in mice.

Authors:  Hal M Hoffman; Peter Scott; James L Mueller; Amir Misaghi; Sean Stevens; George D Yancopoulos; Andrew Murphy; David M Valenzuela; Ru Liu-Bryan
Journal:  Arthritis Rheum       Date:  2010-07

2.  Successful treatment of chronic tophaceous gout with infliximab (Remicade).

Authors:  Christoph Fiehn; Martin Zeier
Journal:  Rheumatol Int       Date:  2005-06-03       Impact factor: 2.631

3.  Sirt1 inhibits gouty arthritis via activating PPARγ.

Authors:  Juan Wang; Guangliang Chen; Liangjing Lu; Hejian Zou
Journal:  Clin Rheumatol       Date:  2019-07-31       Impact factor: 2.980

Review 4.  An old disease with new insights: Update on diagnosis and treatment of gout.

Authors:  Berivan Bitik; M Akif Öztürk
Journal:  Eur J Rheumatol       Date:  2014-06-01

Review 5.  Protein misfolding and dysregulated protein homeostasis in autoinflammatory diseases and beyond.

Authors:  Amma F Agyemang; Stephanie R Harrison; Richard M Siegel; Michael F McDermott
Journal:  Semin Immunopathol       Date:  2015-05-21       Impact factor: 9.623

6.  Activation of human fibroblast-like synoviocytes by uric acid crystals in rheumatoid arthritis.

Authors:  Da P Chen; Chun K Wong; Lai S Tam; Edmund K Li; Christopher W K Lam
Journal:  Cell Mol Immunol       Date:  2011-09-26       Impact factor: 11.530

7.  Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils.

Authors:  B N Cronstein; Y Molad; J Reibman; E Balakhane; R I Levin; G Weissmann
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

Review 8.  Mechanisms of inflammation in gout.

Authors:  Nathalie Busso; Alexander So
Journal:  Arthritis Res Ther       Date:  2010-04-26       Impact factor: 5.156

Review 9.  Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis.

Authors:  Bruce N Cronstein; Prashanth Sunkureddi
Journal:  J Clin Rheumatol       Date:  2013-01       Impact factor: 3.517

Review 10.  Beyond Joints: a Review of Ocular Abnormalities in Gout and Hyperuricemia.

Authors:  Yael Sharon; Naomi Schlesinger
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.